PMID- 27899816
OWN - NLM
STAT- MEDLINE
DCOM- 20170621
LR  - 20220408
IS  - 1759-5053 (Electronic)
IS  - 1759-5045 (Linking)
VI  - 14
IP  - 3
DP  - 2017 Mar
TI  - Bariatric surgery for obesity and metabolic disorders: state of the art.
PG  - 160-169
LID - 10.1038/nrgastro.2016.170 [doi]
AB  - Obesity is one of the most important public health conditions worldwide. 
      Bariatric surgery for severe obesity is an effective treatment that results in 
      the improvement and remission of many obesity-related comorbidities, as well as 
      providing sustained weight loss and improvement in quality of life. Contemporary 
      bariatric operations include Roux-en-Y gastric bypass, sleeve gastrectomy, 
      adjustable gastric band and the duodenal switch. The vast majority of these 
      procedures are now performed using laparoscopic technique, the main advantages of 
      which include rapid recovery, the reduction of postoperative pain and the 
      reduction of wound-related complications, compared with open surgery. 
      Contemporary bariatric surgery is now safe, with a mortality of three in 1,000 
      patients; however, all bariatric operations are associated with their own unique 
      short-term and long-term nutritional and procedural-related complications. Type 2 
      diabetes mellitus (T2DM) is the most studied metabolic disorder associated with 
      obesity, with data demonstrating that improvement and remission of T2DM in 
      patients with obesity is superior after bariatric surgery compared with 
      conventional medical therapy. Bariatric surgery is now a part of some treatment 
      algorithms for the medical management of patients with T2DM and severe obesity. 
      New, minimally invasive and endoscopic devices for the treatment of obesity have 
      now been approved in the USA, which will expand the treatment options for 
      individuals with obesity.
FAU - Nguyen, Ninh T
AU  - Nguyen NT
AD  - Department of Surgery, University of California Irvine Medical Center, 333 City 
      Boulevard West, Suite 1600, Orange, California 92868, USA.
FAU - Varela, J Esteban
AU  - Varela JE
AD  - Diabetes Surgery Institute, 8025 Bonhomme Avenue, Clayton, St. Louis, Missouri 
      63105, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20161130
PL  - England
TA  - Nat Rev Gastroenterol Hepatol
JT  - Nature reviews. Gastroenterology & hepatology
JID - 101500079
SB  - IM
MH  - Bariatric Surgery/adverse effects/*methods
MH  - Diabetes Mellitus, Type 2/complications/*surgery
MH  - Humans
MH  - Laparoscopy
MH  - Obesity, Morbid/complications/*surgery
MH  - Postoperative Complications/etiology/prevention & control
MH  - Quality of Life
MH  - Treatment Outcome
EDAT- 2016/12/03 06:00
MHDA- 2017/06/22 06:00
CRDT- 2016/12/01 06:00
PHST- 2016/12/03 06:00 [pubmed]
PHST- 2017/06/22 06:00 [medline]
PHST- 2016/12/01 06:00 [entrez]
AID - nrgastro.2016.170 [pii]
AID - 10.1038/nrgastro.2016.170 [doi]
PST - ppublish
SO  - Nat Rev Gastroenterol Hepatol. 2017 Mar;14(3):160-169. doi: 
      10.1038/nrgastro.2016.170. Epub 2016 Nov 30.